Anna Juncker‐Jensen
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
- Immunology top 10%
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 9
-
- Cell Adhesion Molecules Research 5
- Co-authors
- Ewa Zając (4 shared papers)James P. Quigley (4 shared papers)Tatyana A. Kupriyanova (4 shared papers)Elena I. Deryugina (4 shared papers)Lisa M. Welter (1 shared paper)Bernhard Schweighofer (2 shared papers)Leif R. Lund (7 shared papers)Petra Minder (1 shared paper)
- Journals
- Annals of Oncology (2 papers)PLoS ONE (2 papers)Cancer Research (1 paper)Nature Medicine (1 paper)The FASEB Journal (1 paper)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Anna Juncker‐Jensen
20 papers receiving 846 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 223
- Immunology 279
- Immunology and Allergy 67
- Oncology 233
- Rehabilitation 27
Countries citing papers authored by Anna Juncker‐Jensen
This map shows the geographic impact of Anna Juncker‐Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Juncker‐Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Juncker‐Jensen more than expected).
Fields of papers citing papers by Anna Juncker‐Jensen
This network shows the impact of papers produced by Anna Juncker‐Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Juncker‐Jensen. The network helps show where Anna Juncker‐Jensen may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Juncker‐Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 260 | |
| 2 | 2013 | 220 | |
| 3 | 2013 | 69 | |
| 4 | 2023 | 52 | |
| 5 | 2008 | 48 | |
| 6 | 2006 | 38 | |
| 7 | 2007 | 37 | |
| 8 | 2011 | 26 | |
| 9 | 2012 | 24 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 19 | |
| 12 | 2023 | 15 | |
| 13 | 2008 | 10 | |
| 14 | 2012 | 7 | |
| 15 | 2023 | 4 | |
| 16 | 2012 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2008 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2023 | 1 |
About Anna Juncker‐Jensen
Anna Juncker‐Jensen is a scholar working on Cancer Research, Immunology and Allergy, Oncology, Immunology and Hematology, having authored 20 papers that have together received 859 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Immune cells in cancer (6 papers), Cell Adhesion Molecules Research (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Research and Treatments (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (223 citations), Immunology (279 citations), Immunology and Allergy (67 citations), Oncology (233 citations) and Rehabilitation (27 citations). Anna Juncker‐Jensen has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Ewa Zając, James P. Quigley, Tatyana A. Kupriyanova, Elena I. Deryugina, Lisa M. Welter, Bernhard Schweighofer, Leif R. Lund, Petra Minder, John Rømer and Kasper Almholt. Their work appears in journals such as Annals of Oncology, PLoS ONE, Cancer Research, Nature Medicine and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.